1066 Objectives: To evaluate 11 C-PIB amyloid deposition in basal ganglia in amnestic and
non-amnestic MCI patients (A-MCI and NA-MCI) and their evolutive changes in comparison …

478 Aim: It is assumed that the abnormal amyloid-β deposition is an initiating event in
Alzheimer9s disease (AD). We evaluated the Pittsburgh compound-B-PET images of very …

It is of great clinical value to identify subjects at a high risk of developing AD. We previously
found that the amyloid positron emission tomography (PET) tracer PIB showed a robust …

Purpose The characteristic neuropathological changes in Alzheimer's disease (AD) are
deposition of amyloid senile plaques and neurofibrillary tangles. The 18 F-labeled amyloid …

Objective The objective of this study was to evaluate the contribution of amyloid imaging with
11 C-Pittsburgh compound B (11 C-PIB) and of glucose metabolism on 18 F …

Purpose The aim of this study was to evaluate amyloid imaging with 11 C-PIB PET/CT in the
study of cognitive impairment in a clinical setting. Patients and Methods The study included …

A 5-year longitudinal evaluation in patients with mild cogni... : Nuclear Medicine
Communications A 5-year longitudinal evaluation in patients with mild cognitive impairment by …

382 Objectives Quantitative assessment of beta-amyloid (Aβ) accumulation over time may
prove critical for understanding the development of pathology in preclinical stages of …

Purpose In subjects with amyloid deposition, striatal accumulation of 11 C-Pittsburgh
compound B (PiB) demonstrated by positron emission tomography (PET) is related to the …

137 Objectives: In-vivo amyloid imaging with PET is allowing new insights into Aβ deposition
in the brain. Longitudinal studies allow researchers to more clearly define the role of Aβ …